PDS Biotechnology Corporation
DE ˙ DB ˙ US70465T1079
€0,99 0,00 (0,00%)
2026-06-04
HİSSE FİYATI
SecurityDE:EU6 / PDS Biotechnology Corporation
InstitutionUBS Group AG
Latest Disclosed Ownership56,004 shares
Latest Disclosed Value $ 33,882
UBS Group AG reports 77.75% decrease in ownership of EU6 / PDS Biotechnology Corporation

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 56,004 shares of PDS Biotechnology Corporation (DE:EU6) valued at $26,019 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 251,705 shares of PDS Biotechnology Corporation. This represents a change in shares of -77.75% during the quarter. The current value of the position is $55,668 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F PDS BIOTECHNOLOGY COM 70465T107 56,004 -195,701 -77.75 34 -82.90 0.0000
2026-01-29 2025-12-31 13F PDS BIOTECHNOLOGY COM 70465T107 251,705 51,469 25.70 194 -4.46 0.0000
2025-11-13 2025-09-30 13F PDS BIOTECHNOLOGY COM 70465T107 200,236 -342,785 -63.13 202 -72.02 0.0000
2025-08-14 2025-06-30 13F PDS BIOTECHNOLOGY COM 70465T107 543,021 291,865 116.21 722 142.28 0.0001
2025-05-13 2025-03-31 13F PDS BIOTECHNOLOGY COM 70465T107 251,156 201,098 401.73 299 267.90 0.0001
2025-02-14 2024-12-31 13F PDS BIOTECHNOLOGY COM 70465T107 50,058 29,824 147.40 82 5.19 0.0000
2024-11-14 2024-09-30 13F PDS BIOTECHNOLOGY COM 70465T107 20,234 -39,754 -66.27 77 -56.00 0.0000
2024-08-14 2024-06-30 13F PDS BIOTECHNOLOGY COM 70465T107 59,988 17,101 39.87 176 3.55 0.0000
2024-05-13 2024-03-31 13F PDS BIOTECHNOLOGY COM 70465T107 42,887 27,074 171.21 170 116.67 0.0000
2024-02-09 2023-12-31 13F PDS BIOTECHNOLOGY COM 70465T107 15,813 15,338 3,229.05 79 3,800.00 0.0000
2023-11-09 2023-09-30 13F PDS BIOTECHNOLOGY COM 70465T107 475 -7,025 -93.67 2 -94.59 0.0000
2023-08-11 2023-06-30 13F PDS BIOTECHNOLOGY COM 70465T107 7,500 4,900 188.46 38 146.67 0.0000
2023-05-12 2023-03-31 13F PDS BIOTECHNOLOGY COM 70465T107 2,600 2,600 16 0.0000
2023-02-08 2022-12-31 13F PDS BIOTECHNOLOGY COM 70465T107 0 -9,883 -100.00 0 -100.00
2022-11-10 2022-09-30 13F PDS BIOTECHNOLOGY COM 70465T107 9,883 9,883 30 0.0000
2022-08-10 2022-06-30 13F PDS BIOTECHNOLOGY COM 70465T107 0 -2,499 -100.00 0 -100.00
2022-05-16 2022-03-31 13F PDS BIOTECHNOLOGY COM 70465T107 2,499 2,499 15 0.0000
2022-02-14 2021-12-31 13F PDS BIOTECHNOLOGY COM 70465T107 0 -2,946 -100.00 0 -100.00
2021-11-15 2021-09-30 13F PDS BIOTECHNOLOGY COM 70465T107 2,946 2,946 44 0.0000
2021-05-12 2021-03-31 13F PDS BIOTECHNOLOGY COM 70465T107 0 -104,890 -100.00 0 -100.00
2021-02-11 2020-12-31 13F PDS BIOTECHNOLOGY COM 70465T107 104,890 1,311 1.27 224 -7.05 0.0001
2020-11-12 2020-09-30 13F PDS BIOTECHNOLOGY COM 70465T107 103,579 103,579 241 0.0001
2020-07-31 2020-06-30 13F PDS BIOTECHNOLOGY COM 70465T107 0 -38,400 -100.00 0 -100.00
2020-05-01 2020-03-31 13F PDS BIOTECHNOLOGY COM 70465T107 38,400 32,950 604.59 28 100.00 0.0000
2020-02-14 2019-12-31 13F PDS BIOTECHNOLOGY COM 70465T107 5,450 5,450 14 0.0000
2019-11-14 2019-09-30 13F PDS BIOTECHNOLOGY COM 70465T107 0 -1,583 -100.00 0 -100.00
2019-08-14 2019-06-30 13F PDS BIOTECHNOLOGY COM 70465T107 1,583 1,583 9 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.